For those who don’t know,Roslyn, where Dr. Zelenko’s protocol will be tested, is in my neck of the woods — Long Island, NY, not far from the City of New York itself ( just 10 minutes drive from the borough of Queens ).
HERE IS THE LATEST DEVELOPMENT:
Two groups will receive different antibiotics.
Cardiologist Dr. Avni Thakore is the studys principal investigator.
What we know about the mechanism of action of the drugs suggests they could be helpful early in the course of a viral infection, said Thakore. We know zinc is an anti-viral. We know that hydroxychloroquine can help reduce an immune response that can get out of control. We also know zinc helps the hydroxychloroquine come inside the cell.
Administered early, rather than as a Hail Mary for the sickest which has had disappointing results, and to protect participants from any increased heart risk that have prompted safety concerns, Thakore notes we are going to be monitoring their EKG from home.
In all touted treatments, data is first needed, says cardiologist Dr. Alan Kadish, president of Touro College.
All drugs have side effects and we dont want to treat millions of people with a combination that we dont know is safe and effective, said Kadish.
If we can manage this early and control it, and prevent people from getting very sick and hospitalized, thats where we need to have good data and good science, said Thakore.
Zelenko, whos offered up his cases for peer review, is hopeful.
This is an absolute revolution in how this disease will be treated, he said.
The study will enroll 750 patients with early symptoms.
To see if you are eligible for this clinical trial, download this St. Francis Hospital criteria and either call 516-414-3056 or visit the St. Francis Hospital emergency room if you suspect you have early COVID-19 symptoms.
Hasn’t Zelenko already appeared on Fox News over a month ago?